GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003070521 | Liver | HCC | cytoskeleton-dependent intracellular transport | 111/7958 | 195/18723 | 3.25e-05 | 3.28e-04 | 111 |
GO:0047496 | Liver | HCC | vesicle transport along microtubule | 34/7958 | 47/18723 | 3.27e-05 | 3.29e-04 | 34 |
GO:0098930 | Liver | HCC | axonal transport | 43/7958 | 64/18723 | 5.73e-05 | 5.31e-04 | 43 |
GO:00109702 | Liver | HCC | transport along microtubule | 90/7958 | 155/18723 | 6.49e-05 | 5.92e-04 | 90 |
GO:0051646 | Liver | HCC | mitochondrion localization | 34/7958 | 50/18723 | 2.38e-04 | 1.79e-03 | 34 |
GO:00064862 | Liver | HCC | protein glycosylation | 122/7958 | 226/18723 | 3.11e-04 | 2.21e-03 | 122 |
GO:00434132 | Liver | HCC | macromolecule glycosylation | 122/7958 | 226/18723 | 3.11e-04 | 2.21e-03 | 122 |
GO:00995182 | Liver | HCC | vesicle cytoskeletal trafficking | 46/7958 | 73/18723 | 3.23e-04 | 2.28e-03 | 46 |
GO:00700852 | Liver | HCC | glycosylation | 128/7958 | 240/18723 | 4.35e-04 | 2.92e-03 | 128 |
GO:00083331 | Liver | HCC | endosome to lysosome transport | 35/7958 | 55/18723 | 1.26e-03 | 6.92e-03 | 35 |
GO:001097511 | Liver | HCC | regulation of neuron projection development | 220/7958 | 445/18723 | 1.68e-03 | 8.78e-03 | 220 |
GO:0008089 | Liver | HCC | anterograde axonal transport | 32/7958 | 50/18723 | 1.76e-03 | 9.12e-03 | 32 |
GO:0009100 | Liver | HCC | glycoprotein metabolic process | 193/7958 | 387/18723 | 1.89e-03 | 9.62e-03 | 193 |
GO:00507674 | Liver | HCC | regulation of neurogenesis | 181/7958 | 364/18723 | 3.00e-03 | 1.40e-02 | 181 |
GO:0051654 | Liver | HCC | establishment of mitochondrion localization | 20/7958 | 29/18723 | 3.61e-03 | 1.60e-02 | 20 |
GO:0034643 | Liver | HCC | establishment of mitochondrion localization, microtubule-mediated | 18/7958 | 26/18723 | 5.37e-03 | 2.24e-02 | 18 |
GO:0047497 | Liver | HCC | mitochondrion transport along microtubule | 18/7958 | 26/18723 | 5.37e-03 | 2.24e-02 | 18 |
GO:0048311 | Liver | HCC | mitochondrion distribution | 12/7958 | 16/18723 | 8.74e-03 | 3.40e-02 | 12 |
GO:001635811 | Liver | HCC | dendrite development | 121/7958 | 243/18723 | 1.26e-02 | 4.56e-02 | 121 |
GO:0006605113 | Thyroid | PTC | protein targeting | 180/5968 | 314/18723 | 6.81e-21 | 1.19e-18 | 180 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TRAK2 | SNV | Missense_Mutation | novel | c.1044N>C | p.Lys348Asn | p.K348N | O60296 | protein_coding | deleterious(0) | probably_damaging(0.966) | TCGA-A2-A3XY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | PD |
TRAK2 | SNV | Missense_Mutation | | c.202G>C | p.Asp68His | p.D68H | O60296 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-A8-A08P-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | CR |
TRAK2 | SNV | Missense_Mutation | | c.1327N>C | p.Glu443Gln | p.E443Q | O60296 | protein_coding | tolerated(0.59) | benign(0.011) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TRAK2 | SNV | Missense_Mutation | rs774108541 | c.836N>A | p.Arg279Gln | p.R279Q | O60296 | protein_coding | deleterious(0.01) | probably_damaging(0.938) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TRAK2 | SNV | Missense_Mutation | novel | c.2135N>A | p.Ser712Tyr | p.S712Y | O60296 | protein_coding | deleterious(0) | possibly_damaging(0.883) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TRAK2 | SNV | Missense_Mutation | rs201575231 | c.1763N>A | p.Arg588Gln | p.R588Q | O60296 | protein_coding | deleterious(0) | possibly_damaging(0.878) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TRAK2 | SNV | Missense_Mutation | novel | c.1118N>A | p.Ser373Tyr | p.S373Y | O60296 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TRAK2 | SNV | Missense_Mutation | | c.1116N>C | p.Glu372Asp | p.E372D | O60296 | protein_coding | tolerated(1) | benign(0.003) | TCGA-B6-A0RL-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TRAK2 | SNV | Missense_Mutation | | c.2517N>C | p.Lys839Asn | p.K839N | O60296 | protein_coding | deleterious(0) | probably_damaging(0.966) | TCGA-D8-A1J8-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | nolvadex | SD |
TRAK2 | SNV | Missense_Mutation | | c.2197N>G | p.Thr733Ala | p.T733A | O60296 | protein_coding | tolerated(0.38) | benign(0.006) | TCGA-E2-A1IH-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | aromasin | SD |